Mukesh Gupta, MD
Cardiovascular Disease · Owensboro, KYNPI 1679567655
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $206, more than ten times the $14 reported in 2020. That places this record below the midpoint for cardiovascular disease clinicians in KY, where the typical reported total is $2,503.
Across 18 payments — averaging $22.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$82
- Boston Scientific$66
- Penumbra, Inc.$65
- Abiomed$41
- Amgen$33
- Johnson & Johnson$30
- plus $91 from 5 others
What the payments were for
- Food & beverage$407100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 4 | $82 |
| Boston Scientific | 3 | $66 |
| Penumbra, Inc. | 1 | $65 |
| Abiomed | 1 | $41 |
| Amgen | 2 | $33 |
| Johnson & Johnson | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Bridgebio Pharma, Inc. | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $14 |
How this compares
$407 in reported general payments places this provider in the 15th percentile of 258 cardiovascular disease providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $22,868 |
| EntrestoSacubitril/Valsartan | 13 | $8,438 |
| BrilintaTicagrelor | 15 | $7,106 |
| Nifedipine ErNifedipine | 30 | $784 |
| Metoprolol Succinate | 51 | $718 |
| ClopidogrelClopidogrel Bisulfate | 81 | $651 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 17 | $441 |
| Atorvastatin Calcium | 63 | $412 |
| Carvedilol | 57 | $410 |
| Losartan Potassium | 35 | $284 |
| Hydralazine Hcl | 36 | $284 |
| Nitroglycerin | 18 | $158 |
| Spironolactone | 26 | $138 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 12 | $113 |
| Lisinopril | 26 | $112 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Owensboro
- Madhura MylaOwensboro$58K
- Kishor VoraOwensboro$21K
- Amir PirachaLouisville$530K
- Dinesh KalraLouisville$316K
- William SkinnerLexington$312K
- Prabodh MehtaElizabethtown$133K
- John HarrisLouisville$129K
- David MoliternoLexington$115K
- Rohan SamsonLouisville$94K
- Srinivasa AppakonduHazard$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.